The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Target Validation, 2011Lamp-2a as a Therapeutic Target in Parkinson's Disease
Objective/Rationale:
Multiple pieces of evidence converge on the notion that accumulation of the protein alpha-synuclein is important for Parkinson’s disease (PD) pathogenesis. One of the ways through... -
Rapid Response Innovation Awards, 2011Direct Reprogramming of Cells into Dopamine Neurons
Objective/Rationale:
The availability of dopaminergic neurons for in-depth study or therapeutic replacement approaches has traditionally been limited. We aim to reprogram cells into dopaminergic... -
Rapid Response Innovation Awards, 2011Whole Exome Sequencing in an Amish Parkinson's Disease Pedigree
Objective/Rationale:
Although there is strong evidence to suggest genetics plays a role in Parkinson’s disease, the majority of the genes involved in Parkinson’s disease remain unidentified. We... -
LRRK2 Target Engagement Ligand, 2011Evaluating Novel Small Molecule Inhibitors of LRRK2 to Deliver PET Ligands
Objective/Rationale:
The exciting discovery of activating mutations in the LRRK2 kinase in familial PD patients, coupled with the emergence of kinase inhibitors as a new class of efficacious drugs... -
Rapid Response Innovation Awards, 2011Developing a Human Neural Model for Parkinson's Disease
Objective/Rationale:
Advances in the knowledge and treatment of Parkinson’s disease (PD) are limited by the inability to obtain, grow and study neural cells from the brains of living patients. Small... -
MJFF Research Grant, 2011Development and Test of a P25a Competitive Alpha-synuclein Aggregate Binding Assay and Test of Thioflavin-T as Competitor
Objective/Rationale:
Compounds targeting aggregated alpha-synuclein are high in demand as potential bio-imaging tools. We have previously developed an assay that measures the binding of the protein...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.